Identity confirms that the peptide is exactly what the label says it is
However, they stressed that the findings show only positive links not established evidence of safety or therapeutic benefit during or before pregnancy
In the UK, Wegovy is recommended by NICE (TA875) for managing weight in adults with a BMI of 35 kg/m or above (or 32.5 kg/m or above for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity
Future research should focus on long-term outcomes, optimal treatment protocols, patient selection criteria, and strategies to ensure equitable access
all sessions should be administered by licensed medical professionals in a clinical setting